Idorsia Ltd (IDRSF)
USD 1.0
(0.0%)
USD 1.0
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 145.23 Million CHF | 38.93% |
| 2022 | 90.83 Million CHF | 424.58% |
| 2021 | 17.31 Million CHF | 105.6% |
| 2020 | -309.31 Million CHF | 25.41% |
| 2019 | -414.7 Million CHF | -34.01% |
| 2018 | -309.46 Million CHF | -8026.28% |
| 2017 | -3.8 Million CHF | 78.98% |
| 2016 | -18.12 Million CHF | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 2.68 Million CHF | -84.26% |
| 2024 Q2 | 11.28 Million CHF | 477.19% |
| 2023 Q1 | 20.17 Million CHF | -61.08% |
| 2023 Q3 | 78.47 Million CHF | 206.91% |
| 2023 Q2 | 25.56 Million CHF | 26.75% |
| 2023 FY | 126.2 Million CHF | 38.93% |
| 2023 Q4 | 17.07 Million CHF | -78.25% |
| 2022 FY | 90.83 Million CHF | 424.58% |
| 2022 Q4 | 51.83 Million CHF | 188.07% |
| 2022 Q3 | 17.99 Million CHF | 59.2% |
| 2022 Q2 | 11.3 Million CHF | 125688.89% |
| 2022 Q1 | -9000.00 CHF | -101.44% |
| 2021 Q3 | -79.31 Million CHF | 9.19% |
| 2021 Q1 | -90.58 Million CHF | -5.75% |
| 2021 Q2 | -87.34 Million CHF | 3.58% |
| 2021 FY | 17.31 Million CHF | 105.6% |
| 2021 Q4 | 625 Thousand CHF | 100.79% |
| 2020 Q4 | -85.66 Million CHF | -0.61% |
| 2020 Q2 | -46.77 Million CHF | 49.02% |
| 2020 Q1 | -91.74 Million CHF | 14.69% |
| 2020 Q3 | -85.14 Million CHF | -82.04% |
| 2020 FY | -309.31 Million CHF | 25.41% |
| 2019 Q2 | -103.64 Million CHF | -0.67% |
| 2019 FY | -414.7 Million CHF | -34.01% |
| 2019 Q4 | -107.54 Million CHF | -6.93% |
| 2019 Q3 | -100.57 Million CHF | 2.96% |
| 2019 Q1 | -102.95 Million CHF | -22.89% |
| 2018 Q3 | -99.67 Million CHF | -52.44% |
| 2018 FY | -309.46 Million CHF | -8026.28% |
| 2018 Q4 | -83.77 Million CHF | 15.95% |
| 2018 Q2 | -65.38 Million CHF | -7.83% |
| 2018 Q1 | -60.63 Million CHF | -166.29% |
| 2017 Q2 | 82.64 Million CHF | 190.94% |
| 2017 Q3 | -55.42 Million CHF | -167.07% |
| 2017 Q4 | 91.47 Million CHF | 265.03% |
| 2017 Q1 | -90.88 Million CHF | 0.0% |
| 2017 FY | -3.8 Million CHF | 78.98% |
| 2016 FY | -18.12 Million CHF | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Evofem Biosciences, Inc. | 11.7 Million USD | -1140.697% |
| Santhera Pharmaceuticals Holding AG | 119.1 Million USD | -21.937% |
| Acro Biomedical Co., Ltd. | 140.5 Thousand USD | -103270.819% |
| Arch Therapeutics, Inc. | -2439.00 USD | 5954835.547% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Nascent Biotech, Inc. | -319.5 Thousand USD | 45556.281% |
| Qrons Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | -25.79 Million USD | 662.974% |
| Skye Bioscience, Inc. | -124.25 Thousand USD | 116989.2% |
| BioStem Technologies, Inc. | 15.42 Million USD | -841.572% |
| ProtoKinetix, Incorporated | -48.25 Thousand USD | 301051.118% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -82158.722% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| CSL Limited | 7.56 Billion USD | 98.079% |
| Capstone Therapeutics Corp. | 9.61 Million USD | -1411.143% |
| Adynxx, Inc. | - USD | -Infinity% |
| Eiger BioPharmaceuticals, Inc. | 14.99 Million USD | -868.305% |
| Nanobac Pharmaceuticals, Incorporated | 3102.00 USD | -4681911.605% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| SQZ Biotechnologies Company | 9.79 Million USD | -1382.908% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | -220865.19% |
| Propanc Biopharma, Inc. | -34.15 Thousand USD | 425388.433% |
| Mesoblast Limited | -35.16 Million USD | 512.978% |
| Marizyme, Inc. | 457.7 Thousand USD | -31631.563% |
| Genus plc | 178.7 Million USD | 18.726% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| Pharming Group N.V. | 220.1 Million USD | 34.015% |
| Therapeutic Solutions International, Inc. | 62.22 Thousand USD | -233300.829% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | -35309.165% |
| Nymox Pharmaceutical Corporation | -11 Thousand USD | 1320427.273% |
| ContraFect Corporation | -154 Thousand USD | 94409.091% |
| PsyBio Therapeutics Corp. | -50 Thousand USD | 290572.0% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | -189105.456% |
| IMV Inc. | -962.29 Thousand USD | 15192.622% |
| AXIM Biotechnologies, Inc. | -387.5 Thousand USD | 37580.161% |
| MultiCell Technologies, Inc. | 49.32 USD | -294476785.645% |
| ONE Bio Corp. | 20.12 Million USD | -621.654% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 40.26 Million USD | -260.7% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 48.9 Thousand USD | -296906.135% |
| Q BioMed Inc. | -8988.00 USD | 1615987.85% |
| Emmaus Life Sciences, Inc. | 28.25 Million USD | -414.019% |
| Mosaic ImmunoEngineering Inc. | - USD | -Infinity% |
| Biomind Labs Inc. | -15.42 Thousand USD | 941723.444% |
| American Oriental Bioengineering, Inc. | 44.35 Million USD | -227.419% |
| Provectus Biopharmaceuticals, Inc. | -1.14 Million USD | 12822.456% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | -207380.0% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| THC Farmaceuticals, Inc. | -4952.00 USD | 2932975.606% |
| Curative Biotechnology, Inc. | -97.51 Thousand USD | 149037.087% |
| GB Sciences, Inc. | -624.00 USD | 23275100.0% |
| Alpha Cognition Inc. | -86.02 Thousand USD | 168924.104% |
| HST Global, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Halberd Corporation | -208.00 USD | 69825100.0% |
| Enzolytics Inc. | 30.7 Thousand USD | -472858.187% |
| Agentix Corp. | - USD | -Infinity% |
| Resverlogix Corp. | - USD | -Infinity% |
| Nuo Therapeutics, Inc. | 482.43 Thousand USD | -30004.906% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 1.1 Billion USD | 86.898% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | -514.51 Thousand USD | 28328.023% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | -23424.419% |
| Zenith Capital Corp. | - USD | -Infinity% |
| Genscript Biotech Corporation | 409.55 Million USD | 64.538% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | -8856.00 USD | 1640072.9% |
| WPD Pharmaceuticals Inc. | - USD | -Infinity% |
| Cotinga Pharmaceuticals Inc. | -83.84 Thousand USD | 173311.368% |
| Kadimastem Ltd | -630.13 Thousand USD | 23148.285% |
| Helix BioMedix, Inc. | 987.98 Thousand USD | -14600.283% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | - USD | -Infinity% |
| LadRx Corporation | -11.83 Thousand USD | 1227273.638% |
| Cell Source, Inc. | - USD | -Infinity% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -82158.722% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Affymax, Inc. | 1.35 Million USD | -10601.599% |
| Itoco Inc. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | - USD | -Infinity% |
| CytoDyn Inc. | -29 Thousand USD | 500913.793% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 450.04 Thousand USD | -32171.583% |
| SYBLEU INC | 11.69 Thousand USD | -1241657.866% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | -Infinity% |
| International Stem Cell Corporation | 4.6 Million USD | -3051.823% |
| Bioxytran, Inc. | -8285.00 USD | 1753099.396% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | - USD | -Infinity% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | -373 Thousand USD | 39037.265% |
| Neutra Corp. | 14.33 Thousand USD | -1013056.61% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 177217.073% |
| PureTech Health plc | -1.6 Million USD | 9160.262% |
| Coeptis Therapeutics, Inc. | -1 Million USD | 14605.671% |
| IXICO plc | 3.27 Million USD | -4341.468% |
| IntelGenx Technologies Corp. | -694 Thousand USD | 21027.378% |
| Gelesis Holdings, Inc. | -1.79 Million USD | 8209.213% |
| CSL Limited | 7.7 Billion USD | 98.115% |
| Cellectis S.A. | 18 Thousand USD | -806766.667% |